The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Kaplan M. A. , Oruc Z., Gumus M. , Ozaydm S., ELKIRAN E. T. , Dine N. S. , ...More

JOURNAL OF BUON, vol.24, no.3, pp.1081-1086, 2019 (Journal Indexed in SCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 3
  • Publication Date: 2019
  • Title of Journal : JOURNAL OF BUON
  • Page Numbers: pp.1081-1086


Purpose: To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based chemotherapy and paclitaxel.